Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
157M
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
15.3M
-
Shares change
-
+1.43M
-
Total reported value, excl. options
-
$242M
-
Value change
-
+$26.3M
-
Put/Call ratio
-
0.21
-
Number of buys
-
50
-
Number of sells
-
-20
-
Price
-
$15.84
Significant Holders of TG THERAPEUTICS, INC. - Common Stock (TGTX) as of Q4 2014
88 filings reported holding TGTX - TG THERAPEUTICS, INC. - Common Stock as of Q4 2014.
TG THERAPEUTICS, INC. - Common Stock (TGTX) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.3M shares
of 157M outstanding shares and own 9.73% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (2.05M shares), FMR LLC (1.93M shares), BRIDGER MANAGEMENT, LLC (1.78M shares), Visium Asset Management, LP (1.2M shares), VANGUARD GROUP INC (1.05M shares), JPMORGAN CHASE & CO (798K shares), BlackRock Fund Advisors (764K shares), BlackRock Institutional Trust Company, N.A. (514K shares), EAM Investors, LLC (431K shares), and Candriam Luxembourg S.C.A. (380K shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.